Surmodics Price to Free Cash Flow Ratio 2010-2025 | SRDX
Historical price to free cash flow ratio values for Surmodics (SRDX) since 2010.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Surmodics Price to Free Cash Flow Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM FCF per Share | Price to FCF Ratio |
| 2025-07-15 | 31.33 | 0.00 | |
| 2025-03-31 | 30.53 | $-0.52 | 0.00 |
| 2024-12-31 | 39.60 | $-0.13 | 0.00 |
| 2024-09-30 | 38.78 | $-0.23 | 0.00 |
| 2024-06-30 | 42.04 | $-0.41 | 0.00 |
| 2024-03-31 | 29.34 | $1.61 | 18.22 |
| 2023-12-31 | 36.35 | $0.71 | 51.25 |
| 2023-09-30 | 32.09 | $0.54 | 59.27 |
| 2023-06-30 | 31.31 | $0.28 | 110.95 |
| 2023-03-31 | 22.78 | $-1.84 | 0.00 |
| 2022-12-31 | 34.12 | $-1.76 | 0.00 |
| 2022-09-30 | 30.40 | $-1.48 | 0.00 |
| 2022-06-30 | 37.23 | $-1.38 | 0.00 |
| 2022-03-31 | 45.33 | $-0.92 | 0.00 |
| 2021-12-31 | 48.15 | $0.57 | 84.62 |
| 2021-09-30 | 55.60 | $0.72 | 76.93 |
| 2021-06-30 | 54.25 | $0.86 | 63.20 |
| 2021-03-31 | 56.07 | $1.52 | 36.79 |
| 2020-12-31 | 43.52 | $0.53 | 82.56 |
| 2020-09-30 | 38.91 | $0.75 | 51.98 |
| 2020-06-30 | 43.24 | $1.45 | 29.80 |
| 2020-03-31 | 33.32 | $0.53 | 63.09 |
| 2019-12-31 | 41.43 | $0.45 | 92.79 |
| 2019-09-30 | 45.74 | $0.09 | 488.68 |
| 2019-06-30 | 43.17 | $-0.46 | 0.00 |
| 2019-03-31 | 43.48 | $-0.73 | 0.00 |
| 2018-12-31 | 47.26 | $1.03 | 45.92 |
| 2018-09-30 | 74.65 | $1.52 | 49.21 |
| 2018-06-30 | 55.20 | $1.71 | 32.26 |
| 2018-03-31 | 38.05 | $2.20 | 17.26 |
| 2017-12-31 | 28.00 | $0.49 | 57.54 |
| 2017-09-30 | 31.00 | $0.57 | 54.46 |
| 2017-06-30 | 28.15 | $0.47 | 60.43 |
| 2017-03-31 | 24.05 | $0.74 | 32.42 |
| 2016-12-31 | 25.40 | $0.87 | 29.06 |
| 2016-09-30 | 30.09 | $1.29 | 23.31 |
| 2016-06-30 | 23.48 | $1.15 | 20.50 |
| 2016-03-31 | 18.41 | $1.14 | 16.14 |
| 2015-12-31 | 20.27 | $1.03 | 19.67 |
| 2015-09-30 | 21.84 | $1.00 | 21.94 |
| 2015-06-30 | 23.42 | $1.24 | 18.94 |
| 2015-03-31 | 26.03 | $1.31 | 19.90 |
| 2014-12-31 | 22.10 | $1.28 | 17.21 |
| 2014-09-30 | 18.16 | $1.17 | 15.50 |
| 2014-06-30 | 21.42 | $1.19 | 17.99 |
| 2014-03-31 | 22.60 | $1.08 | 20.94 |
| 2013-12-31 | 24.39 | $1.08 | 22.68 |
| 2013-09-30 | 23.78 | $1.08 | 21.98 |
| 2013-06-30 | 20.01 | $1.02 | 19.58 |
| 2013-03-31 | 27.25 | $1.01 | 27.06 |
| 2012-12-31 | 22.36 | $1.17 | 19.08 |
| 2012-09-30 | 20.22 | $0.97 | 20.90 |
| 2012-06-30 | 17.30 | $0.98 | 17.73 |
| 2012-03-31 | 15.37 | $0.82 | 18.76 |
| 2011-12-31 | 14.66 | $0.99 | 14.87 |
| 2011-09-30 | 9.10 | $1.22 | 7.44 |
| 2011-06-30 | 11.10 | $1.49 | 7.47 |
| 2011-03-31 | 12.50 | $1.48 | 8.43 |
| 2010-12-31 | 11.87 | $1.20 | 9.86 |
| 2010-09-30 | 11.92 | $1.13 | 10.52 |
| 2010-06-30 | 16.41 | $0.48 | 34.10 |
| 2010-03-31 | 20.94 | $0.18 | 117.91 |
| 2009-12-31 | 22.66 | $0.38 | 59.60 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.449B | $0.126B |
| Surmodics is a leading provider of medical device and In Vitro Diagnostics (IVD) technologies to the healthcare industry. It reports through two divisions: Medical Devices & IVD.?The Medical Devices segment comprises surface modification coating technologies to improve access, deliverability, and predictable deployment of medical devices, international cardiology and peripheral balloon design, development and manufacturing, as well as drug delivery coating technologies to provide site-specific drug delivery from the surface of a medical device, with end markets that include coronary, peripheral, neuro-vascular and urology, among others. The IVD segment includes component products and technologies for diagnostic test kits and biomedical research applications, with products that include protein stabilization reagents, substrates, antigens and surface coatings. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $229.711B | 27.62 |
| Boston Scientific (BSX) | United States | $154.351B | 38.64 |
| Stryker (SYK) | United States | $149.416B | 31.24 |
| EssilorLuxottica (ESLOY) | France | $132.057B | 0.00 |
| Medtronic (MDT) | Ireland | $115.083B | 16.32 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.624B | 0.00 |
| Haleon (HLN) | United Kingdom | $44.474B | 25.39 |
| ResMed (RMD) | United States | $37.259B | 27.99 |
| Agilent Technologies (A) | United States | $34.110B | 22.24 |
| GE HealthCare Technologies (GEHC) | United States | $34.090B | 16.18 |
| Terumo (TRUMY) | Japan | $24.459B | 31.77 |
| Koninklijke Philips (PHG) | Netherlands | $23.149B | 16.24 |
| Insulet (PODD) | United States | $20.550B | 80.67 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.570B | 11.93 |
| Baxter (BAX) | United States | $14.641B | 10.93 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.157B | 0.00 |
| Demant (WILYY) | Denmark | $8.633B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $8.561B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.825B | 23.75 |
| Lantheus Holdings (LNTH) | United States | $5.747B | 14.50 |
| Prestige Consumer Healthcare (PBH) | United States | $3.776B | 16.87 |
| Perrigo (PRGO) | Ireland | $3.768B | 9.55 |
| Haemonetics (HAE) | United States | $3.683B | 16.77 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.395B | 28.21 |
| ICU Medical (ICUI) | United States | $3.220B | 23.75 |
| QuidelOrtho (QDEL) | United States | $1.952B | 13.42 |
| LeMaitre Vascular (LMAT) | United States | $1.900B | 42.47 |
| AtriCure (ATRC) | United States | $1.550B | 0.00 |
| Acuren (TIC) | United States | $1.455B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.374B | 30.91 |
| Phibro Animal Health (PAHC) | United States | $1.278B | 16.34 |
| AdaptHealth (AHCO) | United States | $1.237B | 12.56 |
| Neogen (NEOG) | United States | $1.133B | 14.50 |
| BioLife Solutions (BLFS) | United States | $1.053B | 0.00 |
| InMode (INMD) | Israel | $0.932B | 9.39 |
| Kestra Medical Technologies (KMTS) | United States | $0.792B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.749B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.680B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.661B | 0.00 |
| Owens & Minor (OMI) | United States | $0.616B | 5.11 |
| Evolus (EOLS) | United States | $0.613B | 0.00 |
| CeriBell (CBLL) | United States | $0.592B | 0.00 |
| Valneva SE (VALN) | France | $0.517B | 0.00 |
| SNDL (SNDL) | Canada | $0.415B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.337B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.327B | 12.02 |
| Sanuwave Health (SNWV) | United States | $0.310B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.306B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.304B | 0.00 |
| Quanterix (QTRX) | United States | $0.302B | 0.00 |
| Cerus (CERS) | United States | $0.277B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.266B | 22.40 |
| Aurora Cannabis (ACB) | Canada | $0.257B | 76.33 |
| Sanara MedTech (SMTI) | United States | $0.257B | 0.00 |
| ZimVie (ZIMV) | United States | $0.249B | 11.30 |
| Brainsway (BWAY) | Israel | $0.231B | 61.17 |
| Omeros (OMER) | United States | $0.230B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.230B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.226B | 0.00 |
| Biote (BTMD) | United States | $0.221B | 6.22 |
| Canopy Growth (CGC) | Canada | $0.215B | 0.00 |
| Organigram Global (OGI) | Canada | $0.198B | 0.00 |
| High Tide (HITI) | Canada | $0.195B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.188B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.184B | 15.00 |
| Vireo Growth (VREOF) | United States | $0.162B | 0.00 |
| Exagen (XGN) | United States | $0.151B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.123B | 15.13 |
| TerrAscend (TSNDF) | Canada | $0.115B | 0.00 |
| Fonar (FONR) | United States | $0.101B | 13.05 |
| MacroGenics (MGNX) | United States | $0.100B | 0.00 |
| Jin Medical (ZJYL) | China | $0.094B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.092B | 0.00 |
| Veru (VERU) | United States | $0.089B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.087B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.083B | 0.00 |
| Apyx Medical (APYX) | United States | $0.074B | 0.00 |
| InterCure (INCR) | Israel | $0.071B | 0.00 |
| Agape ATP (ATPC) | $0.069B | 0.00 | |
| Cytosorbents (CTSO) | United States | $0.066B | 0.00 |
| Zynex (ZYXI) | United States | $0.064B | 0.00 |
| ImmuCell (ICCC) | United States | $0.059B | 0.00 |
| Nephros (NEPH) | United States | $0.040B | 54.00 |
| Safety Shot (SHOT) | United States | $0.040B | 0.00 |
| Modular Medical (MODD) | United States | $0.039B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.038B | 0.00 |
| United-Guardian (UG) | United States | $0.037B | 12.87 |
| Allurion Technologies (ALUR) | United States | $0.021B | 0.00 |
| Flora Growth (FLGC) | United States | $0.016B | 0.00 |
| INLIF (INLF) | $0.015B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.014B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.013B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.013B | 0.00 |
| Senestech (SNES) | United States | $0.011B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| Sharps Technology (STSS) | United States | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |